-
2
-
-
84864426225
-
Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study
-
The EUROCARE Working Group 21607946 10.1002/ijc.26192 1:CAS:528:DC%2BC38XhtFWms7%2FJ
-
Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, Mangone L, Francisci S, The EUROCARE Working Group (2012) Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer 131:1649-1658
-
(2012)
Int J Cancer
, vol.131
, pp. 1649-1658
-
-
Brenner, H.1
Bouvier, A.M.2
Foschi, R.3
Hackl, M.4
Larsen, I.K.5
Lemmens, V.6
Mangone, L.7
Francisci, S.8
-
3
-
-
28544446695
-
Biomarkers in cancer staging, prognosis and treatment selection
-
16239904 10.1038/nrc1739 1:CAS:528:DC%2BD2MXht1WitLbP
-
Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5:845-856
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 845-856
-
-
Ludwig, J.A.1
Weinstein, J.N.2
-
4
-
-
0033587747
-
CpG island methylator phenotype in colorectal cancer
-
10411935 10.1073/pnas.96.15.8681 1:CAS:528:DyaK1MXkslOktLg%3D
-
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681-8686
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 8681-8686
-
-
Toyota, M.1
Ahuja, N.2
Ohe-Toyota, M.3
Herman, J.G.4
Baylin, S.B.5
Issa, J.P.6
-
5
-
-
79958173795
-
Colorectal cancer: Molecular features and clinical opportunities
-
20498827
-
Worthley DL, Leggett BA (2010) Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev 31:31-38
-
(2010)
Clin Biochem Rev
, vol.31
, pp. 31-38
-
-
Worthley, D.L.1
Leggett, B.A.2
-
6
-
-
84923426582
-
Promoter CpG island methylation in colorectal cancer
-
K. Appasani (eds) 1 Cambridge University Press Cambridge
-
Derks S, van Engeland M (2012) Promoter CpG island methylation in colorectal cancer. In: Appasani K (ed) Epigenomics: from chromatin biology to therapeutics, 1st edn. Cambridge University Press, Cambridge, pp 307-308
-
(2012)
Epigenomics: From Chromatin Biology to Therapeutics
, pp. 307-308
-
-
Derks, S.1
Van Engeland, M.2
-
7
-
-
80054758533
-
The role of methylation in gene expression
-
Philips T (2008) The role of methylation in gene expression. Nat Edu 1:127
-
(2008)
Nat Edu
, vol.1
, pp. 127
-
-
Philips, T.1
-
8
-
-
0028074299
-
DNA methylation and cancer
-
7849743 1:CAS:528:DyaK2cXmsVOhtrc%3D
-
Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3:1487-1495
-
(1994)
Hum Mol Genet
, vol.3
, pp. 1487-1495
-
-
Laird, P.W.1
Jaenisch, R.2
-
9
-
-
49249121155
-
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer
-
18519671 10.1158/0008-5472.CAN-08-0325 1:CAS:528:DC%2BD1cXmsFKmtLo%3D
-
Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123-4132
-
(2008)
Cancer Res
, vol.68
, pp. 4123-4132
-
-
Toyota, M.1
Suzuki, H.2
Sasaki, Y.3
Maruyama, R.4
Imai, K.5
Shinomura, Y.6
Tokino, T.7
-
10
-
-
70350731129
-
Epigenetic regulation of microRNA expression in colorectal cancer
-
19521961 10.1002/ijc.24638 1:CAS:528:DC%2BD1MXht1WmsLnM
-
Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125:2737-2743
-
(2009)
Int J Cancer
, vol.125
, pp. 2737-2743
-
-
Bandres, E.1
Agirre, X.2
Bitarte, N.3
Ramirez, N.4
Zarate, R.5
Roman-Gomez, J.6
Prosper, F.7
Garcia-Foncillas, J.8
-
11
-
-
77958489647
-
Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
-
20676129 10.1038/onc.2010.305 1:CAS:528:DC%2BC3cXpsFWku7c%3D
-
Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29:5724-5728
-
(2010)
Oncogene
, vol.29
, pp. 5724-5728
-
-
Hildebrandt, M.A.1
Gu, J.2
Lin, J.3
Ye, Y.4
Tan, W.5
Tamboli, P.6
Wood, C.G.7
Wu, X.8
-
12
-
-
80052929478
-
CpG island methylation in colorectal cancer: Past, present and future
-
10.4061/2011/902674 21559209
-
Curtin K, Slattery ML, Samowitz WS (2011) CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int 2011:902674. doi: 10.4061/2011/902674
-
(2011)
Patholog Res Int
, vol.2011
, pp. 902674
-
-
Curtin, K.1
Slattery, M.L.2
Samowitz, W.S.3
-
13
-
-
33846192840
-
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer
-
17087942 10.1053/j.gastro.2006.09.018 1:CAS:528:DC%2BD2sXit1aqsLY%3D
-
Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM et al (2007) The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132:127-138
-
(2007)
Gastroenterology
, vol.132
, pp. 127-138
-
-
Goel, A.1
Nagasaka, T.2
Arnold, C.N.3
Inoue, T.4
Hamilton, C.5
Niedzwiecki, D.6
Compton, C.7
Mayer, R.J.8
Goldberg, R.9
Bertagnolli, M.M.10
-
14
-
-
78649985198
-
Update on the serrated pathway to colorectal carcinoma
-
20869746 10.1016/j.humpath.2010.06.002
-
Snover DC (2011) Update on the serrated pathway to colorectal carcinoma. Hum Pathol 42:1-10
-
(2011)
Hum Pathol
, vol.42
, pp. 1-10
-
-
Snover, D.C.1
-
15
-
-
79955397102
-
DNA methylation predicts recurrence from resected stage III proximal colon cancer
-
21509761 10.1002/cncr.25737 1:CAS:528:DC%2BC3MXkvFarsbc%3D
-
Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, Chung HC, Kim NK, Issa JP (2011) DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer 117:1847-1854
-
(2011)
Cancer
, vol.117
, pp. 1847-1854
-
-
Ahn, J.B.1
Chung, W.B.2
Maeda, O.3
Shin, S.J.4
Kim, H.S.5
Chung, H.C.6
Kim, N.K.7
Issa, J.P.8
-
16
-
-
80052348969
-
Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea
-
21836485 10.1097/PAS.0b013e318224cd2e
-
Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD (2011) Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol 35:1274-1286
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 1274-1286
-
-
Kim, K.M.1
Lee, E.J.2
Ha, S.3
Kang, S.Y.4
Jang, K.T.5
Park, C.K.6
Kim, J.Y.7
Kim, Y.H.8
Chang, D.K.9
Odze, R.D.10
-
17
-
-
77950900898
-
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
-
19638426 10.1093/carcin/bgp179 1:CAS:528:DC%2BC3cXivFGnu7c%3D
-
Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y et al (2010) IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 31:342-349
-
(2010)
Carcinogenesis
, vol.31
, pp. 342-349
-
-
Suzuki, H.1
Igarashi, S.2
Nojima, M.3
Maruyama, R.4
Yamamoto, E.5
Kai, M.6
Akashi, H.7
Watanabe, Y.8
Yamamoto, H.9
Sasaki, Y.10
-
18
-
-
84869053467
-
Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients
-
23255887 1:CAS:528:DC%2BC3sXksl2ltg%3D%3D
-
Dimberg J, Hong TT, Skarstedt M, Löfgren S, Zar N, Matussek A (2013) Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients. Oncol Lett 5:25-30
-
(2013)
Oncol Lett
, vol.5
, pp. 25-30
-
-
Dimberg, J.1
Hong, T.T.2
Skarstedt, M.3
Löfgren, S.4
Zar, N.5
Matussek, A.6
-
19
-
-
77951647898
-
Role of the serrated pathway in colorectal cancer pathogenesis
-
20420948 10.1053/j.gastro.2009.12.066 1:CAS:528:DC%2BC3cXms1yitbo%3D
-
Leggett B, Whitehall V (2010) Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138:2088-2100
-
(2010)
Gastroenterology
, vol.138
, pp. 2088-2100
-
-
Leggett, B.1
Whitehall, V.2
-
20
-
-
34247638013
-
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma
-
17372756 10.1007/s00428-007-0398-3 1:CAS:528:DC%2BD2sXkslWguro%3D
-
Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, Enzinger PC, Wolpin BM, Loda M, Fuchs CS (2007) CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 450:529-537
-
(2007)
Virchows Arch
, vol.450
, pp. 529-537
-
-
Ogino, S.1
Meyerhardt, J.A.2
Kawasaki, T.3
Clark, J.W.4
Ryan, D.P.5
Kulke, M.H.6
Enzinger, P.C.7
Wolpin, B.M.8
Loda, M.9
Fuchs, C.S.10
-
21
-
-
84855755065
-
TFAP2E-DKK4 and chemoresistance in colorectal cancer
-
22216841 10.1056/NEJMoa1009473 1:CAS:528:DC%2BC38XhtVKitL8%3D
-
Ebert MPA, Tänzer M, Balluff B, Burgermeister E, Kretzschmar AK, Hughes DJ, Tetzner R, Lofton-Day C, Rosenberg R, Reinacher-Schick AC et al (2012) TFAP2E-DKK4 and chemoresistance in colorectal cancer. N Engl J Med 366:44-53
-
(2012)
N Engl J Med
, vol.366
, pp. 44-53
-
-
Ebert, M.P.A.1
Tänzer, M.2
Balluff, B.3
Burgermeister, E.4
Kretzschmar, A.K.5
Hughes, D.J.6
Tetzner, R.7
Lofton-Day, C.8
Rosenberg, R.9
Reinacher-Schick, A.C.10
-
22
-
-
84055222098
-
Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNF-α-induced apoptosis
-
21980136 10.1158/1078-0432.CCR-11-1026 1:CAS:528:DC%2BC3MXhs1CqtrjN
-
Lee JH, Kang MJ, Han HY, Lee MG, Jeong SI, Ryu BK, Ha TK, Her NG, Han J, Park SJ et al (2011) Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNF-α-induced apoptosis. Clin Cancer Res 17:7551-7562
-
(2011)
Clin Cancer Res
, vol.17
, pp. 7551-7562
-
-
Lee, J.H.1
Kang, M.J.2
Han, H.Y.3
Lee, M.G.4
Jeong, S.I.5
Ryu, B.K.6
Ha, T.K.7
Her, N.G.8
Han, J.9
Park, S.J.10
-
23
-
-
77449130761
-
Microsatellite instability in colorectal cancer
-
20420947 10.1053/j.gastro.2009.12.064 1:CAS:528:DC%2BC3cXms1yitbw%3D
-
Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138:2073-2087
-
(2010)
Gastroenterology
, vol.138
, pp. 2073-2087
-
-
Boland, C.R.1
Goel, A.2
-
24
-
-
77949759545
-
The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status
-
20197478 10.1158/1078-0432.CCR-09-2594 1:CAS:528:DC%2BC3cXjtFyhur4%3D
-
Dahlin AM, Palmqvist R, Henriksson ML, Jacobsson M, Eklöf V, Rutegård J, Oberg A, Van Guelpen BR (2010) The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res 16:1845-1855
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1845-1855
-
-
Dahlin, A.M.1
Palmqvist, R.2
Henriksson, M.L.3
Jacobsson, M.4
Eklöf, V.5
Rutegård, J.6
Oberg, A.7
Van Guelpen, B.R.8
-
25
-
-
14544300998
-
Systematic review of microsatellite instability and colorectal cancer prognosis
-
15659508 10.1200/JCO.2005.01.086 1:CAS:528:DC%2BD2MXitVartLY%3D
-
Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618
-
(2005)
J Clin Oncol
, vol.23
, pp. 609-618
-
-
Popat, S.1
Hubner, R.2
Houlston, R.S.3
-
26
-
-
84874216566
-
MicroRNAs as novel biomarkers in colorectal cancer
-
10.3389/fgene.2012.00180 23091478
-
Hrašovec S, Glavač D (2012) MicroRNAs as novel biomarkers in colorectal cancer. Front Genet 3:180. doi: 10.3389/fgene.2012.00180
-
(2012)
Front Genet
, vol.3
, pp. 180
-
-
Hrašovec, S.1
Glavač, D.2
-
27
-
-
40549090918
-
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations
-
18048385 10.1093/carcin/bgm270 1:CAS:528:DC%2BD1cXislKhtrw%3D
-
Derks S, Postma C, Carvalho B, van den Bosch SM, Moerkerk PT, Herman JG, Weijenberg MP, de Bruïne AP, Meijer GA, van Engeland M (2008) Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 29:434-439
-
(2008)
Carcinogenesis
, vol.29
, pp. 434-439
-
-
Derks, S.1
Postma, C.2
Carvalho, B.3
Van Den Bosch, S.M.4
Moerkerk, P.T.5
Herman, J.G.6
Weijenberg, M.P.7
De Bruïne, A.P.8
Meijer, G.A.9
Van Engeland, M.10
-
28
-
-
83355163991
-
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
-
22168215 10.1186/1741-7015-9-133 1:CAS:528:DC%2BC38XisFyrsbg%3D
-
Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 9:133-141
-
(2011)
BMC Med
, vol.9
, pp. 133-141
-
-
Warren, J.D.1
Xiong, W.2
Bunker, A.M.3
Vaughn, C.P.4
Furtado, L.V.5
Roberts, W.L.6
Fang, J.C.7
Samowitz, W.S.8
Heichman, K.A.9
-
29
-
-
84866661786
-
Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers
-
10.1371/journal.pone.0046000 23155391 10.1371/journal.pone.0048547
-
Tóth K, Sipos F, Kalmar A, Patai AV, Wichmann B, Stoehr R, Golcher H, Scheller V, Tulassay Z, Molnár B (2012) Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One 7(11):e48547. doi: 10.1371/journal.pone.0046000
-
(2012)
PLoS One
, vol.7
, Issue.11
, pp. 48547
-
-
Tóth, K.1
Sipos, F.2
Kalmar, A.3
Patai, A.V.4
Wichmann, B.5
Stoehr, R.6
Golcher, H.7
Scheller, V.8
Tulassay, Z.9
Molnár, B.10
-
31
-
-
84879289642
-
Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer
-
23747112 10.1016/j.jmoldx.2013.03.004 1:CAS:528:DC%2BC3sXptFGls7s%3D
-
Oh T, Kim N, Moon Y, Soon Kim M, Hoehn BD, Hee Park C, Soo Kim T, Kyu Kim N, Cheol Chung H, An S (2013) Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn 15:498-507
-
(2013)
J Mol Diagn
, vol.15
, pp. 498-507
-
-
Oh, T.1
Kim, N.2
Moon, Y.3
Soon Kim, M.4
Hoehn, B.D.5
Hee Park, C.6
Soo Kim, T.7
Kyu Kim, N.8
Cheol Chung, H.9
An, S.10
-
32
-
-
77955783215
-
RUNX3 promoter methylation in colorectal cancer: Its relationship with microsatellite instability and its suitability as a novel serum tumor marker
-
20682997 1:CAS:528:DC%2BC3cXhtFWgur%2FI
-
Nishio M, Sakakura C, Nagata T, Komiyama S, Miyashita A, Hamada T, Kuryu Y, Ikoma H, Kubota T, Kimura A et al (2010) RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Anticancer Res 30:2673-2682
-
(2010)
Anticancer Res
, vol.30
, pp. 2673-2682
-
-
Nishio, M.1
Sakakura, C.2
Nagata, T.3
Komiyama, S.4
Miyashita, A.5
Hamada, T.6
Kuryu, Y.7
Ikoma, H.8
Kubota, T.9
Kimura, A.10
-
33
-
-
84856751013
-
Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients
-
23359753 10.1007/s11670-011-0283-0 1:CAS:528:DC%2BC3MXhs1Oit77K
-
Wu PP, Zou JH, Tang RN, Yao Y, You CZ (2011) Detection and clinical significance of DLC1 gene methylation in serum DNA from colorectal cancer patients. Chin J Cancer Res 23:283-287
-
(2011)
Chin J Cancer Res
, vol.23
, pp. 283-287
-
-
Wu, P.P.1
Zou, J.H.2
Tang, R.N.3
Yao, Y.4
You, C.Z.5
-
34
-
-
79957971986
-
Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer
-
21326223 10.1038/ajg.2011.6 1:CAS:528:DC%2BC3MXmvFyjtbo%3D
-
Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A, Crispin A, Neumann J, Lamerz R, Kolligs FT (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol 106:1110-1118
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 1110-1118
-
-
Herbst, A.1
Rahmig, K.2
Stieber, P.3
Philipp, A.4
Jung, A.5
Ofner, A.6
Crispin, A.7
Neumann, J.8
Lamerz, R.9
Kolligs, F.T.10
-
35
-
-
67649635452
-
N-myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer
-
19535783 10.1093/jnci/djp131 1:CAS:528:DC%2BD1MXosVWmu70%3D
-
Melotte V, Lentjes MHFM, van den Bosch SM, Hellenbrekers DMEI, de Hoon JPJ, Wouters KAD, Daenen KLJ, Partouns-Hendriks IEJM, Stressels F, Louwagie J et al (2009) N-myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 101:916-927
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 916-927
-
-
Melotte, V.1
Lentjes, M.2
Van Den Bosch, S.M.3
Hellenbrekers, D.4
De Hoon, J.P.J.5
Wouters, K.A.D.6
Daenen, K.L.J.7
Partouns-Hendriks, I.8
Stressels, F.9
Louwagie, J.10
-
36
-
-
66349102768
-
Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer
-
19435926 10.1158/0008-5472.CAN-08-0142
-
Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruïne AP, Smits KM et al (2009) Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 69:4691-4699
-
(2009)
Cancer Res
, vol.69
, pp. 4691-4699
-
-
Glöckner, S.C.1
Dhir, M.2
Yi, J.M.3
McGarvey, K.E.4
Van Neste, L.5
Louwagie, J.6
Chan, T.A.7
Kleeberger, W.8
De Bruïne, A.P.9
Smits, K.M.10
-
37
-
-
77953733668
-
Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer
-
20530429 1:CAS:528:DC%2BC3cXovV2gs7k%3D
-
Hibi K, Goto T, Kitamura YH, Yokomizo K, Sakuraba K, Shirahata A, Mizukami H, Saito M, Ishibashi K, Kigawa G et al (2010) Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer. Anticancer Res 30:1205-1207
-
(2010)
Anticancer Res
, vol.30
, pp. 1205-1207
-
-
Hibi, K.1
Goto, T.2
Kitamura, Y.H.3
Yokomizo, K.4
Sakuraba, K.5
Shirahata, A.6
Mizukami, H.7
Saito, M.8
Ishibashi, K.9
Kigawa, G.10
-
38
-
-
80052166888
-
Detection of TFPI2 methylation in the serum of colorectal cancer patients
-
21820798 10.1016/j.canlet.2011.07.006 1:CAS:528:DC%2BC3MXhtV2iu7bE
-
Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y (2011) Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett 311:96-100
-
(2011)
Cancer Lett
, vol.311
, pp. 96-100
-
-
Hibi, K.1
Goto, T.2
Shirahata, A.3
Saito, M.4
Kigawa, G.5
Nemoto, H.6
Sanada, Y.7
-
39
-
-
74749100743
-
Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer
-
20113832 10.1016/j.cancergencyto.2009.11.004 1:CAS:528: DC%2BC3cXhtlGhs74%3D
-
Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T (2010) Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Cancer Genet Cytogenet 197:16-24
-
(2010)
Cancer Genet Cytogenet
, vol.197
, pp. 16-24
-
-
Takada, H.1
Wakabayashi, N.2
Dohi, O.3
Yasui, K.4
Sakakura, C.5
Mitsufuji, S.6
Taniwaki, M.7
Yoshikawa, T.8
-
40
-
-
67449128445
-
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
-
19509152 10.1158/1078-0432.CCR-09-0055 1:CAS:528:DC%2BD1MXntlOis7o%3D
-
Hellebrekers DMEI, Lentjes MHFM, van den Bosch SM, Melotte V, Wouters KAD, Daenen KLJ, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S et al (2009) GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 15:3990-3997
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3990-3997
-
-
Hellebrekers, D.1
Lentjes, M.2
Van Den Bosch, S.M.3
Melotte, V.4
Wouters, K.A.D.5
Daenen, K.L.J.6
Smits, K.M.7
Akiyama, Y.8
Yuasa, Y.9
Sanduleanu, S.10
-
41
-
-
40049096639
-
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening
-
18203283 10.3748/wjg.14.524 1:CAS:528:DC%2BD1cXjvFKksLY%3D
-
Wang DR, Tang D (2008) Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol 14:524-531
-
(2008)
World J Gastroenterol
, vol.14
, pp. 524-531
-
-
Wang, D.R.1
Tang, D.2
-
42
-
-
79960558168
-
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
-
21777459 10.1186/1476-4598-10-85 1:CAS:528:DC%2BC3MXhtVGhtLbL
-
Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G et al (2011) Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer 10:85-99
-
(2011)
Mol Cancer
, vol.10
, pp. 85-99
-
-
Lind, G.E.1
Danielsen, S.A.2
Ahlquist, T.3
Merok, M.A.4
Andresen, K.5
Skotheim, R.I.6
Hektoen, M.7
Rognum, T.O.8
Meling, G.I.9
Hoff, G.10
-
43
-
-
84857194577
-
The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia
-
22019796 10.1016/j.cgh.2011.10.008 1:CAS:528:DC%2BC38XislSqtLc%3D
-
Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, Boardman LA, Berger BM, Lidgard GP (2012) The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol 10:272-277
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 272-277
-
-
Ahlquist, D.A.1
Taylor, W.R.2
Mahoney, D.W.3
Zou, H.4
Domanico, M.5
Thibodeau, S.N.6
Boardman, L.A.7
Berger, B.M.8
Lidgard, G.P.9
-
44
-
-
84880063991
-
DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer
-
10.1158/1940-6207.CAPR-12-0501 1:CAS:528:DC%2BC3sXhtVGltbzO
-
Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF et al (2013) DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res 6:656-665
-
(2013)
Cancer Prev Res
, vol.6
, pp. 656-665
-
-
Carmona, F.J.1
Azuara, D.2
Berenguer-Llergo, A.3
Fernández, A.F.4
Biondo, S.5
De Oca, J.6
Rodriguez-Moranta, F.7
Salazar, R.8
Villanueva, A.9
Fraga, M.F.10
-
45
-
-
70349656779
-
Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer
-
19773381 10.1158/1078-0432.CCR-09-0111 1:CAS:528:DC%2BD1MXhtF2lurrI
-
Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH (2009) Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15:6185-6191
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6185-6191
-
-
Lee, B.B.1
Lee, E.J.2
Jung, E.H.3
Chun, H.K.4
Chang, D.K.5
Song, S.Y.6
Park, J.7
Kim, D.H.8
-
46
-
-
77953192081
-
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
-
19876917 10.1002/ijc.25007 1:CAS:528:DC%2BC3cXlsVOrsLs%3D
-
Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127:118-126
-
(2010)
Int J Cancer
, vol.127
, pp. 118-126
-
-
Huang, Z.1
Huang, D.2
Ni, S.3
Peng, Z.4
Sheng, W.5
Du, X.6
-
47
-
-
77957375434
-
MicroRNAs as biomarkers in colorectal cancer
-
20829435 10.2353/ajpath.2010.100024 1:CAS:528:DC%2BC3cXhsVSqu7vJ
-
Schee K, Fodstad Ø, Flatmark K (2010) MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 177:1592-1599
-
(2010)
Am J Pathol
, vol.177
, pp. 1592-1599
-
-
Schee, K.1
Fodstad Ø2
Flatmark, K.3
-
48
-
-
44449125989
-
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer
-
18264139 10.1038/onc.2008.10 1:CAS:528:DC%2BD1cXntlCqurc%3D
-
Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Wilson JKV, Kaz AM et al (2008) Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27:3880-3888
-
(2008)
Oncogene
, vol.27
, pp. 3880-3888
-
-
Grady, W.M.1
Parkin, R.K.2
Mitchell, P.S.3
Lee, J.H.4
Kim, Y.H.5
Tsuchiya, K.D.6
Washington, M.K.7
Paraskeva, C.8
Wilson, J.K.V.9
Kaz, A.M.10
-
49
-
-
84872836602
-
SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer
-
22821729 10.1002/path.4078 1:CAS:528:DC%2BC38XhvVOrtrzN
-
Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, Yang YZ, Moyer MP, Zhang HZ, Chen HQ, Liang Y et al (2013) SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 229:12-24
-
(2013)
J Pathol
, vol.229
, pp. 12-24
-
-
Wang, F.1
Ma, Y.L.2
Zhang, P.3
Shen, T.Y.4
Shi, C.Z.5
Yang, Y.Z.6
Moyer, M.P.7
Zhang, H.Z.8
Chen, H.Q.9
Liang, Y.10
-
50
-
-
84872902302
-
CD133 as a biomarker for putative cancer stem cells in solid tumours: Limitations, problems and challenges
-
22899341 10.1002/path.4086 1:CAS:528:DC%2BC3sXhsFeqsL8%3D
-
Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, Kunz-Schughart LA (2013) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol 229:355-378
-
(2013)
J Pathol
, vol.229
, pp. 355-378
-
-
Grosse-Gehling, P.1
Fargeas, C.A.2
Dittfeld, C.3
Garbe, Y.4
Alison, M.R.5
Corbeil, D.6
Kunz-Schughart, L.A.7
-
51
-
-
79956095406
-
PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis
-
21558389 10.1158/0008-5472.CAN-10-2342 1:CAS:528:DC%2BC3MXmtVGltb8%3D
-
Sakthianandeswaren A, Christie M, D'Andreti C, Tsui C, Jorissen RN, Li S, Fleming NI, Gibbs P, Lipton L, Malaterre J et al (2011) PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Res 71:3709-3719
-
(2011)
Cancer Res
, vol.71
, pp. 3709-3719
-
-
Sakthianandeswaren, A.1
Christie, M.2
D'Andreti, C.3
Tsui, C.4
Jorissen, R.N.5
Li, S.6
Fleming, N.I.7
Gibbs, P.8
Lipton, L.9
Malaterre, J.10
-
52
-
-
84875551747
-
MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features
-
10.1371/journal.pone.0059064 23555617 10.1371/journal.pone.0059064 1:CAS:528:DC%2BC3sXmtFWrsr8%3D
-
Li X, Yao X, Wang Y, Hu F, Wang F, Jiang L, Liu Y, Wang D, Sun G, Zhao Y (2013) MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One 8(3):e59064. doi: 10.1371/journal.pone.0059064
-
(2013)
PLoS One
, vol.8
, Issue.3
, pp. 59064
-
-
Li, X.1
Yao, X.2
Wang, Y.3
Hu, F.4
Wang, F.5
Jiang, L.6
Liu, Y.7
Wang, D.8
Sun, G.9
Zhao, Y.10
-
53
-
-
34247570795
-
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
-
17591929 10.2353/jmoldx.2007.060170 1:CAS:528:DC%2BD2sXot1Kqsr8%3D
-
Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9:305-314
-
(2007)
J Mol Diagn
, vol.9
, pp. 305-314
-
-
Ogino, S.1
Kawasaki, T.2
Kirkner, G.J.3
Kraft, P.4
Loda, M.5
Fuchs, C.S.6
-
54
-
-
79958179303
-
Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients
-
21587258 10.1038/bjc.2011.165 1:CAS:528:DC%2BC3MXntV2hsbs%3D
-
Rawson JB, Mrkonjic M, Daftary D, Dicks E, Buchanan DD, Younghusband HB, Parfrey PS, Young JP, Pollett A, Green RC et al (2011) Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients. Br J Cancer 104:1906-1912
-
(2011)
Br J Cancer
, vol.104
, pp. 1906-1912
-
-
Rawson, J.B.1
Mrkonjic, M.2
Daftary, D.3
Dicks, E.4
Buchanan, D.D.5
Younghusband, H.B.6
Parfrey, P.S.7
Young, J.P.8
Pollett, A.9
Green, R.C.10
-
55
-
-
61449239306
-
Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer
-
19331161 1:CAS:528:DC%2BD1MXjtFGgsbg%3D
-
Goto T, Mizukami H, Shirahata A, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K (2009) Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Anticancer Res 29:275-277
-
(2009)
Anticancer Res
, vol.29
, pp. 275-277
-
-
Goto, T.1
Mizukami, H.2
Shirahata, A.3
Sakata, M.4
Saito, M.5
Ishibashi, K.6
Kigawa, G.7
Nemoto, H.8
Sanada, Y.9
Hibi, K.10
-
56
-
-
84874587717
-
Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression
-
10.1155/2013/181384 23509688
-
Peng H, Long F, Wu Z, Chu Y, Li J, Kuai R, Zhang J, Kang Z, Zhang X, Guan M (2013) Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression. Biomed Res Int 2013:181384. doi: 10.1155/2013/181384
-
(2013)
Biomed Res Int.
, vol.2013
, pp. 181384
-
-
Peng, H.1
Long, F.2
Wu, Z.3
Chu, Y.4
Li, J.5
Kuai, R.6
Zhang, J.7
Kang, Z.8
Zhang, X.9
Guan, M.10
|